Collectively, these results suggest that tumor-derived G-CSF is involved in the cisplatin resistance in cervical cancer by inducing the production of MDSC, prolonging their survival, and increasing their activities against the cancer cells and the cancer microenvironment (Fig. 2G). This evidence concerns the gene CSF3 and cervical carcinoma.